Scott Patrick Heximer

Dr. Scott Patrick Heximer


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2008 in Circulation Research
Verified
Journal Article
Closed access
PDF file
CCCarlo Cifelli
Carlo Cifelli
RRRobert Rose
Robert Rose
HZHangjun Zhang
Hangjun Zhang
JVJulia Voigtlaender-Bolz
Julia Voigtlaender-Bolz
SBSteffen-Sebastian Bolz
Steffen-Sebastian Bolz
SHScott Patrick Heximer
Scott Patrick Heximer
Heart rate is controlled by the opposing activities of sympathetic and parasympathetic inputs to pacemaker myocytes in the sinoatrial node (SAN). Parasympathetic activity on nodal myocytes is mediated by acetylcholine-dependent stimulation of M 2 muscarinic receptors and activation of Gα i/o signaling. Although regulators of G protein signaling (RGS) proteins are potent inhibitors of Gα i/o signaling in many tissues, the RGS protein(s) that regulate parasympathetic tone in the SAN are unknown. Our results demonstrate that RGS4 mRNA levels are higher in the SAN compared to right atrium. Conscious freely moving RGS4-null mice showed increased bradycardic responses to parasympathetic agonists compared to wild-type animals. Moreover, anesthetized RGS4-null mice had lower baseline heart rates and greater heart rate increases following atropine administration. Retrograde-perfused hearts from RGS4-null mice showed enhanced negative chronotropic responses to carbachol, whereas SAN myocytes showed greater sensitivity to carbachol-mediated reduction in the action potential firing rate. Finally, RGS4-null SAN cells showed decreased levels of G protein–coupled inward rectifying potassium (GIRK) channel desensitization and altered modulation of acetylcholine-sensitive potassium current ( I KACh ) kinetics following carbachol stimulation. Taken together, our studies establish that RGS4 plays an important role in regulating sinus rhythm by inhibiting parasympathetic signaling and I KACh activity.

2 February 2009 in Clinical Science
Verified
Journal Article
Closed access
SGSteven Gu
Steven Gu
CCCarlo Cifelli
Carlo Cifelli
SWSean Wang
Sean Wang
SHScott Patrick Heximer
Scott Patrick Heximer
Understanding the mechanisms that underlie BP (blood pressure) variation in humans and animal models may provide important clues for reducing the burden of uncontrolled hypertension in industrialized societies. High BP is often associated with increased signalling via G-protein-coupled receptors. Three members of the RGS (regulator of G-protein signalling) superfamily RGS2, RGS4 and RGS5 have been implicated in the attenuation of G-protein signalling pathways in vascular and cardiac myocytes, as well as cells of the kidney and autonomic nervous system. In the present review, we discuss the current state of knowledge regarding their differential expression and function in cardiovascular tissues, and the likelihood that one or more of these alleles are candidate hypertension genes. Together, findings from the studies described herein suggest that development of methods to modulate the expression and function of RGS proteins may be a possible strategy for the treatment and prevention of hypertension and cardiovascular disease.

22 April 2025 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
DTDanya Thayaparan
Danya Thayaparan
TETakuo Emoto
Takuo Emoto
AKAniqa B. Khan
Aniqa B. Khan
RBRickvinder Besla
Rickvinder Besla
HHHomaira Hamidzada
Homaira Hamidzada
CRClinton S. Robbins
Clinton S. Robbins

29 September 2011 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
HZHangjun Zhang
Hangjun Zhang
SGSteven Gu
Steven Gu
BABasil Al‐Sabeq
Basil Al‐Sabeq
SWSean Wang
Sean Wang
JHJanet He
Janet He
SHScott Patrick Heximer
Scott Patrick Heximer
Cells from multiple origins contribute to vascular smooth muscle cell (VSMC) development. Phenotypic heterogeneity of VSMCs is associated with their point of developmental origin; however, the mechanisms driving such differences are unknown. We here examined the mechanisms controlling vascular bed‐specific differences in Rgs5 expression during development. Rgs5 levels were similar across different regions of the vasculature in neonatal animals but were >15‐fold higher in descending aortas compared with carotid arteries of adult mice. Thus, vessel bed‐specific changes in regulation of Rgs5 expression occurred during vessel maturation. Examination of adult Rgs5 ‐LacZ reporter mice revealed lower Rgs5 expression in VSMCs originating from the third (carotid artery) branchial arch compared with those originating in the fourth and sixth (aortic B segment, right subclavian, and ductus arteriosus) branchial arches. Indeed, a mosaic Rgs5 expression pattern, with discreet LacZ boundaries between VSMCs derived from different developmental origins, was observed. Furthermore, Rgs5 ‐LacZ expression was correlated with the site of VSMC origin (splanchic mesoderm ≈ local mesenchyme > somites > proepicardium > mesothelium). Surprisingly, Rgs5 reporter activity in cultured carotid artery‐ and descending aorta‐derived cells did not recapitulate the differences observed in vivo . Consistent with a developmental origin‐specific epigenetic mechanism driving the observed expression differences in vivo , the Rgs5 promoter showed increased methylation on CpG dinucleotides in carotid arteries compared with that in descending aortas in adult but not in neonatal mice. In vitro methylation of the Rgs5 promoter confirmed that its activity is sensitive to transcriptional down‐regulation by CpG methylation. These data suggest that an origin‐dependent epigenetic program regulates vascular bed‐ and maturation state‐dependent regulation of VSMC‐specific gene transcription.—Zhang, H., Gu, S., Al‐Sabeq, B., Wang, S., He, J., Tam, A., Cifelli, C., Mathalone, N., Tirgari, S., Boyd, S., Heximer, S. P. Origin‐specific epigenetic program correlates with vascular bedspecific differences in Rgs5 expression. FASEB J. 26, 181–191 (2012). www.fasebj.org

1 July 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
GBGuillaume Bastin
Guillaume Bastin
SHScott Patrick Heximer
Scott Patrick Heximer
RGS4, a heterotrimeric G-protein inhibitor, localizes to plasma membrane (PM) and endosomal compartments. Here, we examined Rab-mediated control of RGS4 internalization and recycling. Wild type and constitutively active Rab5 decreased RGS4 PM levels while increasing its endosomal targeting. Rab5, however, did not appreciably affect the PM localization or function of the M1 muscarinic receptor (M1R)/Gq signaling cascade. RGS4-containing endosomes co-localized with subsets of Rab5-, transferrin receptor-, and Lamp1/Lysotracker-marked compartments suggesting RGS4 traffics through PM recycling or acidified endosome pathways. Rab7 activity promoted TGN association, whereas Rab7(dominant negative) trapped RGS4 in late endosomes. Furthermore, RGS4 was found to co-localize with an endosomal pool marked by Rab11, the protein that mediates recycling/sorting of proteins to the PM. The Cys-12 residue in RGS4 appeared important for its Rab11-mediated trafficking to the PM. Rab11(dominant negative) decreased RGS4 PM levels and increased the number of RGS4-containing endosomes. Inhibition of Rab11 activity decreased RGS4 function as an inhibitor of M1R activity without affecting localization and function of the M1R/Gq signaling complex. Thus, both Rab5 activation and Rab11 inhibition decreased RGS4 function in a manner that is independent from their effects on the localization and function of the M1R/Gq signaling complex. This is the first study to implicate Rab GTPases in the intracellular trafficking of an RGS protein. Thus, Rab GTPases may be novel molecular targets for the selective regulation of M1R-mediated signaling via their specific effects on RGS4 trafficking and function.

23 January 2007 in Science's STKE
Verified
Journal Article
Closed access
PDF file
SHScott Patrick Heximer
Scott Patrick Heximer
KBKendall J. Blumer
Kendall J. Blumer
Coordinated regulation of heterotrimeric guanine nucleotide–binding protein (G protein) activity is critical for the integration of information from multiple intracellular signaling networks. The human regulator of G protein signaling (RGS) protein family contains more than 35 members that are well suited for this purpose. Although all RGS proteins contain a core ~120–amino acid G-interacting domain (called the RGS domain), they differ widely in size and organization of other functional domains. Architecturally complex RGS proteins contain multiple modular protein-protein interaction domains that mediate their interaction with diverse signaling effectors. Architecturally simple RGS proteins contain small amino-terminal domains; however, they show surprising versatility in the number of intracellular partners with which they interact. This Perspective focuses on RGS2, a simple RGS protein with the potential to integrate multiple signaling networks. In three recent studies, the amino-terminal domain of RGS2 was shown to interact with and regulate three different effector proteins: adenylyl cyclase, tubulin, and the cation channel TRPV6. To explain this growing list of RGS2-interacting partners, we propose two models: (i) The amino-terminal domain of RGS2 comprises several short effector protein interaction motifs; (ii) the amino-terminal domain of RGS2 adopts distinct structures to bind various targets. Whatever the precise mechanism controlling its target interactions, these studies suggest that RGS2 is a key point of integration for multiple intracellular signaling pathways, and they highlight the role of RGS proteins as dynamic, multifunctional signaling centers that coordinate a diverse range of cellular functions.